On November 1^st, we held the Cycle 6 IMPACT Pitch-Off, the final IMPACT pitch event of 2023. This event featured 10 digital health startups, leaders from Point32Health, Boston Scientific, UMass Chan Medical School and DeviceTalks, making for an inspirational and exciting evening.

On Thursday, June 15, we partnered with Boston Scientific to run the Connected Patient Challenge (CPC) VII Challenge and Pitch Event. As our first year helping promote and host this event, we were thrilled by the interest our life sciences community had for this Challenge. We met numerous life sciences experts, passionate entrepreneurs, and medical device innovators while at Mintz for the CPC VII Pitch Event.

This year marks the first in-person Point of Care Showcase & Pitch Event since its debut in 2019. We’re thrilled to have a panel of speakers that includes life sciences thought leaders and experienced point of care entrepreneurs.

On April 4th, we held the 5th IMPACT Showcase Day and Accelerator Pitch-Off for the Cycle 5 Cohort. The startups in Cycle 5 spent the day connecting with leading experts and investors in orthopedic innovation. Following the IMPACT Showcase, they shared their technology and unique stories with a packed room of attendees. Eight fantastic companies joined us as Cycle 5 prize sponsors, awarding prizes to each startup.

The 2023 $200K Challenge season brought with it record breaking application numbers and over 200 people headed to the UMass Lowell iHub to learn about the latest in healthcare innovation. This year’s Pitch-Off was an absolute success, and a joy to experience with all of you. Life sciences industry leaders, entrepreneurs from around the world, and medical device innovators joined us in Lowell to learn more about this year’s 15 Finalists.

This past Wednesday, November 30^th, we held our fourth and final IMPACT Pitch-Off for 2022. We were joined by leaders in medical device development from big corporations, including our Cycle 4 Sponsor, Johnson & Johnson Innovation. Over the last 10 weeks they have been working with the 12 startups in Cohort 4 to prepare them for this exciting, competitive event. 

Today we announced the 12 startups selected to participate in Cycle 4 of the IMPACT Accelerator Program. This will be the final IMPACT Cycle of 2022, sponsored by our partner Johnson & Johnson Innovation. Cycle 4 will end with an exciting in-person pitch event on November 30th.

Last Wednesday, we held our very first in-person IMPACT Showcase Day and Accelerator Pitch-Off for the Cycle 3 Cohort. After the IMPACT Showcase, where the startups had sat with strategists and leading experts in women’s health, medtech, and local hospitals, they pitched their technology to a packed room of attendees. The startups in Cohort 3 met with interested investors and innovators, and received awards from SIX prize sponsors, including a whopping $25K in in-kind resources from the Cycle 3 Sponsor Hologic.

The 2022 CAPCaT Big Company/Little Company Showcase speaker lineup will feature authorities on topics that are top-of-mind among current and future medtech innovators: the forward-looking state of the market and the challenge of health equity.

For the third year, M2D2 and the Center for Advancing Point of Care Technologies (CAPCaT) in Heart, Lung, Blood, and Sleep Disorders will present their Big Company/Little Company Showcase.

Happening virtually on Thursday, June 16 from 9am to 1:30 ET, the Showcase is a high-value informational and networking event for life sciences startups seeking to initiate conversations about strategic partnerships with suitable corporate entities.